News Archives

Since 2002, the Partnership for Safe Medicines has been publishing information about the counterfeit drug problem around the world. With experts leading the organization and a committed and passionate set of writers and editors, our content is more in-depth than many other sources, which simply copy links to the news from other websites.

Head of Patient Advocacy Organization Warns That Drug Importation Is Not The Solution American Patients Need

April 18, 2019

In this editorial by Terry Wilcox published in Inside Sources on April 18, 2019, Terry Wilcox, executive director of a patient advocacy organization advices federal and state representatives that allowing drug importation is not the right policy solution for America’s high prescription drug prices…

Canadian law enforcement: Smugglers will exploit importation to traffic counterfeit medicine

April 17, 2019

In this editorial, which was published in Colorado Politics on April 17, 2019, Don Bell, a 30-year veteran of Canadian law enforcement and border protection, warns that Canadian drug importation will open the U.S. to counterfeit medicine and exacerbate drug shortages in Canada.

WHO: Counterfeit medicines kill up to 300,000 children each year

April 15, 2019

Counterfeit medicines kill up to 300,000 children each year In a shocking new report published in the American Journal of Tropical Medicine and Hygiene, researchers have documented the true toll of counterfeit medicines around the world due to medicine being subtherapeutic or outright ineffective. Subtherapeutic medicine allows patients to die without sufficient treatment, but it…

The Wall Street Journal’s Editorial Board Comes Out Against Drug Importation

April 15, 2019

The editorial board of the The Wall Street Journal published this editorial on April 15, 2019. In it, they write:

“The argument that drug importation threatens the integrity of the drug supply is often dismissed because pharmaceutical lobbyists make it. But keeping the drug supply free from contaminated or counterfeit products is not easy, and the World Health Organization has warned that 1 in 10 medical products in the developing world are phony. It isn’t clear who is liable if counterfeits are found in Florida, but you can bet it won’t be the politicians.”

Partnership for Safe Medicines Launches Advertising Campaign in Florida to Oppose Importation

April 12, 2019

April 12, 2019 (Tallahassee, FL) — Importation undermines our core efforts to keep our medicine supply safe. State and federal authorities regulate every entity in the U.S. supply chain from the point of manufacture until a medicine is dispensed, and that makes counterfeits in the legitimate supply chain rare. In 2013, Congress passed the Drug…

U.S. FDA Issued Warning Letters About Misbranded Mifepristone And Misoprostol

April 11, 2019

In March 2019, the U.S. Food and Drug Administration issued warning letters to a website and an online pharmacy network for selling misbranded mifepristone and misoprostol

Drug importation makes law enforcement’s job harder, says former FDA-OCI director

April 11, 2019

In this editorial, which was published in The Gadsden Times on April 11, 2019, former FDA-OCI director George Karavetsos points out the real dangers of drug importation:

“Even today, Americans are being hurt and even dying because of counterfeit medications being imported into this country. Adding insult to injury, while some might point to Canada as being a safe source, counterfeit medications are transshipped through Canada from other countries in remote corners of the globe.”

North Carolina Man Who Imported Counterfeit Xanax from Canada Sentenced to 2 Extra Days in Prison in Sled Border-Crossing Case

April 10, 2019

The News and Record has reported about a North Carolina resident, Yazid Al Fayyad Finn, who was arrested in 2018 for his part in a plot to steal a 200 pound shipment of counterfeit Xanax that was being smuggled across the Quebec-Vermont border.

PRESS RELEASE: Over 100 Organizations Representing Law Enforcement Officers, Healthcare Professionals, Patient Advocates Urge White House and Congress to Reject Prescription Drug Importation

April 9, 2019

WASHINGTON (April 8, 2019) – As members of Congress and leaders in the executive branch consider steps to allow wholesale importation of prescription medications, organizations representing consumers, employers, healthcare professionals, patients, and law enforcement officers, among others, are insisting that such proposals, if implemented, would endanger the health and safety of the communities throughout the country…

Arizona’s Counterfeit Pill Problem Expands

April 8, 2019

On March 15th, two different busts in Arizona highlighted the problems the Grand Canyon State is having with counterfeit pills.